RJRina J. Jaju

Rina J. Jaju

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Rina J. Jaju has a total of 6 co-authors. Here are the top co-authors by number of shared publications:

  • David Y. Mason

    Leukaemia Research Fund Immunodiagnostic Unit, Clinical Laboratory Sciences, University of Oxford, John Radcliffe Hospital, Oxford, U.K

    1 shared publication
  • Jacqueline Boultwood

    University of Oxford, Oxford, United Kingdom

    1 shared publication
  • James S. Wainscoat

    Leukaemia Research Fund Molecular Haematology Unit, Clinical Laboratory Sciences, University of Oxford, John Radcliffe Hospital, Oxford, U.K

    1 shared publication
  • Lyndal Kearney

    Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, U.K

    1 shared publication
  • Margaret Jones

    Leukaemia Research Fund Immunodiagnostic Unit, Clinical Laboratory Sciences, University of Oxford, John Radcliffe Hospital, Oxford, U.K

    1 shared publication
  • Susan Kelly

    Department of Haematology, Wycombe General Hospital, High Wycombe, U.K

    1 shared publication

Latest Publications

  • Combined immunophenotyping and FISH identifies the involvement of B-cells in 5q- syndrome

    by Rina J. Jaju, Margaret Jones, Jacqueline Boultwood, Susan Kelly, David Y. Mason, James S. Wainscoat, Lyndal Kearney

    The 5q‐ syndrome is a distinct subtype of myelodysplastic syndrome (MDS) characterized by refractory anemia, deletion of the long arm of chromosome 5, del(5q), as the sole cytogenetic abnormality, and a low frequency of transformation to acute leukemia. Using combined immunophenotyping and fluorescence in situ hybridization (FISH), studies were carried out on bone marrow smears of three 5q‐ syndrome cases to identify the cell lineages carrying the 5q deletion. In all three cases, the granulocytic, monocytic, and erythroid lineages possessed the del(5q) clonal marker, whereas the T‐lymphocytes did not. Interestingly, in one case, cells of B‐lymphoid lineage also showed the presence of the del(5q). This is the first report to date showing involvement of an acquired 5q deletion associated with MDS in B‐cells. This result suggests that in some cases, MDS arises in a multipotent cell with a capacity to differentiate into both myeloid and lymphoid cells.